Pyrilutamide
Pyrilutamide is a nonsteroidal antiandrogen (NSAA) that is being developed for the treatment of androgenetic alopecia (AGA) and acne. It is a selective antagonist of the androgen receptor (AR), which means it blocks the effects of androgens like testosterone and dihydrotestosterone (DHT) in the body.
Mechanism of Action[edit]
Pyrilutamide works by binding to the androgen receptors in hair follicles and sebaceous glands, preventing androgens from exerting their effects. This action helps to reduce hair loss and improve hair growth in individuals with androgenetic alopecia. In the case of acne, it reduces the production of sebum, which is often stimulated by androgens.
Clinical Development[edit]
Pyrilutamide is currently undergoing clinical trials to evaluate its safety and efficacy. Early studies have shown promising results in reducing hair loss and improving hair density in patients with androgenetic alopecia. Further research is ongoing to confirm these findings and to explore its potential use in treating acne.
Potential Side Effects[edit]
As with other nonsteroidal antiandrogens, potential side effects of pyrilutamide may include local skin reactions at the site of application, such as redness, itching, or irritation. Systemic side effects are expected to be minimal due to its topical application and limited systemic absorption.
Comparison with Other Treatments[edit]
Pyrilutamide is part of a class of medications known as nonsteroidal antiandrogens, which also includes drugs like flutamide, bicalutamide, and enzalutamide. Unlike these systemic treatments, pyrilutamide is designed for topical use, which may reduce the risk of systemic side effects.
See Also[edit]
- Androgenetic alopecia
- Acne
- Androgen receptor
- Nonsteroidal antiandrogen
- Flutamide
- Bicalutamide
- Enzalutamide
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
